Fig. 6
Expression of selected miRNAs in the plasma-derived EVs. Expression of miR-34a-5p (a), miR-127-3p (b), miR-212-3p (c), miR-222-3p (d), and miR-361-5p (e) in HD-derived EVs (n = 10), JAK2V617F-mutated (n = 10), and TN (n = 6) patients. f Expression of miR-361-5p in EVs from JAK2V617F-mutated, and TN patients, respectively. Results are expressed as mean ± SEM (*p ≤ 0.05; **p ≤ 0.01). g-h Linear regression analysis showing positive/negative correlation between JAK2V617F VAF and miR-34a or miR-212, respectively